Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Ordinary Shares, $0.01 par value per share
-
Shares outstanding
-
29M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
2.28M
-
Shares change
-
+1.25M
-
Total reported value, excl. options
-
$2.27M
-
Value change
-
+$1.24M
-
Number of buys
-
8
-
Number of sells
-
-3
-
Price
-
$1.00
Significant Holders of Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) as of Q2 2025
20 filings reported holding ITRM - Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share as of Q2 2025.
Iterum Therapeutics plc - Ordinary Shares, $0.01 par value per share (ITRM) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.28M shares
of 29M outstanding shares and own 7.87% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (472K shares), Squarepoint Ops LLC (457K shares), SABBY MANAGEMENT, LLC (431K shares), New Leaf Venture Partners, L.L.C. (345K shares), Apollon Financial, LLC (250K shares), OneDigital Investment Advisors LLC (161K shares), JANE STREET GROUP, LLC (92.9K shares), TWO SIGMA INVESTMENTS, LP (25.2K shares), GEODE CAPITAL MANAGEMENT, LLC (12.4K shares), and Alpine Global Management, LLC (10K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.